Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results
PARSIPPANY, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the second quarter ended June 30, 2024 and provided a business and financial update.
Related news for (IDXG)
- Interpace Biosciences Announces First Quarter 2025 Financial and Business Results
- Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results
- Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts
- Interpace Biosciences Announces First Quarter 2024 Financial and Business Results